Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities
Net increase (decrease) in net assets resulting from operations	$ 43,433	$ 24,911
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:
Net realized (gain) loss on investments	(393)	0
Net realized (gain) loss on foreign currency forward contracts	(47)	0
Net change in unrealized (appreciation) depreciation on investments	(186)	216
Net change in unrealized (appreciation) depreciation on interest rate swaps and options, inclusive of hedging effects	(892)	0
Net accretion on debt instruments	(4,511)	(2,288)
Net paydown gain on debt instruments	(536)	(128)
Interest received in-kind	(967)	(803)
Purchases and drawdowns of investments	(318,737)	(456,894)
Proceeds from sales and paydowns of investments	102,082	28,002
Net settlements on derivative contracts	0	773
Amortization of deferred financing costs	1,783	630
Amortization of deferred offering costs	612	337
Change in operating assets and liabilities:
(Increase) decrease in interest receivable	189	(2,248)
(Increase) decrease in other assets	545	0
(Increase) decrease in prepaid expenses	483	153
Increase (decrease) in interest payable	(14,909)	337
Increase (decrease) in accrued expenses and other liabilities payable to affiliate	(230)	(968)
Increase (decrease) in income incentive fees payable	621	789
Increase (decrease) in management fees payable	344	318
Increase (decrease) in deferred tax liability	280	311
Increase (decrease) in deferred income	(102)	4
Increase (decrease) in capital gains incentive fees payable	0	(7)
Increase (decrease) in due to affiliate	0	2,298
Net cash used in operating activities	(191,093)	(404,324)
Cash flows from financing activities
Dividends paid	(32,468)	(28,975)
Payments for repurchase of common shares	(6,564)	(487)
Proceeds from issuance of common shares	183,251	246,050
Borrowings on debt	363,700	473,200
Payments on debt	(398,000)	(284,900)
Payments for deferred financing costs	(502)	(1,605)
Payments for deferred offering costs	(550)	(549)
Net cash provided by financing activities	108,867	402,734
Net change in cash	(82,226)	(1,590)
Cash and restricted cash, beginning of period	161,064	62,706
Cash and restricted cash, end of period	78,838	61,116
Supplemental and non-cash information
Distributions reinvested	10,933	4,809
Cash paid during the period for interest	45,535	13,718
Dividends payable	14,964	9,486
The following table provides a reconciliation of cash and restricted cash reported within the consolidated statements of assets and liabilities:
Cash	27,703	30,189
Restricted cash	51,135	30,927
Total cash and restricted cash	78,838	61,116
Foreign currency forward contracts
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities:
Net change in unrealized (appreciation) depreciation on foreign currency forward contracts	$ 45	$ (67)